Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 621-630 of 1772 for

Edit search filters
  1. Study Of AZD0466 Monotherapy Or In Combination In Patients With Advanced Haematological Malignancies

    Jacksonville, FL

  2. AML: Treatment Of Relapse After Transplant Or Extended Maintenance Of Remission – Investigational Study (ARTEMIS) Effectiveness Of MT-401 In Patients With AML Following Stem Cell Transplant

    Jacksonville, FL, Rochester, MN

  3. Diagnostic 68Ga-PSMA-11 PET/CT

    Rochester, MN

  4. A Drug-drug Interaction Study Of Avapritinib And Midazolam To Treat Unresectable Or Metastatic Gastrointestinal Stromal Tumors And Other Advanced Solid Tumors

    Jacksonville, FL

  5. A Phase II Clinical Trial Comparing The Efficacy Of RO7198457 Versus Watchful Waiting In Patients With CtDNA-positive, Resected Stage II (High Risk) And Stage III Colorectal Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. A Study Of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab In Previously Untreated Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma

    Rochester, MN

  7. Abiraterone/Prednisone, Olaparib, Or Abiraterone/Prednisone + Olaparib In Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

    Rochester, MN

  8. A Study Of SC-007 In Subjects With Advanced Cancer

    Rochester, MN

  9. Radiation Therapy With Or Without Apalutamide In Treating Patients With Stage III-IV Prostate Cancer

    Albert Lea, MN

  10. Tucatinib And Trastuzumab For Patients With HER2-positive Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer